180 related articles for article (PubMed ID: 1666894)
41. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD
Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367
[TBL] [Abstract][Full Text] [Related]
42. Collagenase and collagenase inhibitors in osteoarthritic and normal cartilage.
Ehrlich MG; Mankin HJ; Jones H; Wright R; Crispen C; Vigliani G
J Clin Invest; 1977 Feb; 59(2):226-33. PubMed ID: 188866
[TBL] [Abstract][Full Text] [Related]
43. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
[TBL] [Abstract][Full Text] [Related]
44. Effects of ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage.
Sabatini M; Rolland G; Léonce S; Thomas M; Lesur C; Pérez V; de Nanteuil G; Bonnet J
Biochem Biophys Res Commun; 2000 Jan; 267(1):438-44. PubMed ID: 10623638
[TBL] [Abstract][Full Text] [Related]
45. Effect of glucosamine on interleukin-1-conditioned articular cartilage.
Fenton JI; Chlebek-Brown KA; Caron JP; Orth MW
Equine Vet J Suppl; 2002 Sep; (34):219-23. PubMed ID: 12405690
[TBL] [Abstract][Full Text] [Related]
46. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.
DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K
Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566
[TBL] [Abstract][Full Text] [Related]
47. Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation.
Barter MJ; Hui W; Lakey RL; Catterall JB; Cawston TE; Young DA
Ann Rheum Dis; 2010 Dec; 69(12):2189-98. PubMed ID: 20693272
[TBL] [Abstract][Full Text] [Related]
48. Metalloproteinase production by rabbit articular cartilage: comparison of the effects of interleukin-1 alpha in vitro and in vivo.
Hembry RM; Bagga MR; Dingle JT; Thomas PP; Reynolds JJ
Virchows Arch; 1994; 425(4):413-24. PubMed ID: 7529620
[TBL] [Abstract][Full Text] [Related]
49. Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin).
Mast AE; Enghild JJ; Nagase H; Suzuki K; Pizzo SV; Salvesen G
J Biol Chem; 1991 Aug; 266(24):15810-6. PubMed ID: 1651920
[TBL] [Abstract][Full Text] [Related]
50. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate.
Brown CC; Hembry RM; Reynolds JJ
J Bone Joint Surg Am; 1989 Apr; 71(4):580-93. PubMed ID: 2539384
[TBL] [Abstract][Full Text] [Related]
51. Interstitial collagenase (MMP-1), gelatinase (MMP-2) and stromelysin (MMP-3) released by human fibroblasts cultured on acellular sarcoid granulomas (sarcoid matrix complex, SMC).
Emonard H; Takiya C; Dreze S; Cordier JF; Grimaud JA
Matrix; 1989 Nov; 9(5):382-8. PubMed ID: 2559305
[TBL] [Abstract][Full Text] [Related]
52. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis.
Hasty KA; Reife RA; Kang AH; Stuart JM
Arthritis Rheum; 1990 Mar; 33(3):388-97. PubMed ID: 2156511
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase.
Hill PA; Docherty AJ; Bottomley KM; O'Connell JP; Morphy JR; Reynolds JJ; Meikle MC
Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):167-75. PubMed ID: 7755562
[TBL] [Abstract][Full Text] [Related]
54. Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin.
Stack MS; Emberts CG; Gray RD
Arch Biochem Biophys; 1991 Jun; 287(2):240-9. PubMed ID: 1654808
[TBL] [Abstract][Full Text] [Related]
55. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.
Andrews HJ; Plumpton TA; Harper GP; Cawston TE
Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176
[TBL] [Abstract][Full Text] [Related]
56. Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis.
Yocum SA; Lopresti-Morrow LL; Gabel CA; Milici AJ; Mitchell PG
Arch Biochem Biophys; 1995 Feb; 316(2):827-35. PubMed ID: 7864640
[TBL] [Abstract][Full Text] [Related]
57. Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants.
Piecha D; Weik J; Kheil H; Becher G; Timmermann A; Jaworski A; Burger M; Hofmann MW
Inflamm Res; 2010 May; 59(5):379-89. PubMed ID: 19902332
[TBL] [Abstract][Full Text] [Related]
58. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.
Shinmei M; Kikuchi T; Masuda K; Shimomura Y
Drugs; 1988; 35 Suppl 1():33-41. PubMed ID: 2834169
[TBL] [Abstract][Full Text] [Related]
59. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
Ganu V; Melton R; Wang W; Roberts D
Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
[No Abstract] [Full Text] [Related]
60. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Woessner JF
FASEB J; 1991 May; 5(8):2145-54. PubMed ID: 1850705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
